stock decline

Trip.com ($TCOM) tumbled 17% after China's antitrust regulator launched investigation into alleged monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Corcept Therapeutics faces class action lawsuit after FDA rejected lead drug relacorilant in December. Stock fell 50.4%; investors with $100K+ losses have until April 2026 to file suit.

America's Car-Mart stock ($CRMT) plummets 18% after Q1 loss widens to 69 cents per share. Law firm investigates potential securities fraud claims.

Apollo Global Management faces securities lawsuit over undisclosed Jeffrey Epstein ties revealed in investigative reports. Stock plummeted 15%, erasing $12B in market cap.

$ODD crashes 49% after disclosing 30% revenue decline tied to advertising partner algorithm changes and customer acquisition cost surge.

Securities fraud investigation launched against $GEMI after 79% stock collapse following February 2026 pivot announcement and executive departures.

Micron stock declined 3.9% amid concerns over Google's memory-reducing technology and SK Hynix's planned U.S. IPO, threatening chip demand and investor capital.

On Holding's stock plunged 11% after CEO Martin Hoffmann's departure, with co-founders returning as Co-CEOs. The second major leadership change in a year raises investor concerns about governance despite record 2025 sales.

Nike's stock down 60% in five years faces margin pressure from $1.5B in tariffs and flat Q3 2026 guidance. March 31 earnings crucial.

Innovation Beverage Group acquires controlling BlockFuel Energy stake, pivoting from beverages. Stock slides 8% as short interest surges to 47.92% amid execution concerns.

Brookfield and Blackstone shares have tumbled on private credit concerns, but both firms offer attractive valuations with proven track records and multiple growth drivers.

Short-seller Muddy Waters alleges SoFi misreported loan risk and accounting practices. Stock down 50% from 2025 highs; CEO buying aggressively despite denial.

Robbins Geller files class action against monday.com ($MNDY) alleging false revenue projections. Stock plunged 21% after company withdrew 2027 guidance.

U Power stock plunges 20% after announcing 10-for-1 share consolidation approved by shareholders in December 2025, set to take effect March 30, 2026.

Law firm files class actions against uniQure, Gartner, and Trip.com for alleged failure to disclose material information. Stock declines range from 19% to 49%.

Trip.com faces securities fraud lawsuit after Chinese antitrust probe alleges monopolistic practices; stock fell 19.4%. Investors have until May 11, 2026 to file claims.

Gartner faces securities fraud suit after 48% stock decline linked to reduced guidance. Investors can apply as lead plaintiffs through Kahn Swick & Foti, LLC.

Driven Brands Holdings faces securities fraud class action over undisclosed financial statement errors spanning 2023-2025, triggering a 39% stock decline.

Class action lawsuit filed against Corcept Therapeutics alleging securities fraud tied to FDA rejection of relacorilant, triggering 50% stock plunge.

Apollo Global Management faces securities fraud class action over undisclosed Epstein communications. Stock fell 16% during class period; investors can file claims by May 1, 2026.